Xenotransplantation and risks of zoonotic infections

References

• Centers for Disease Control and Prevention. U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. MMWR 2001;50 (RR-15): 1–46 or Food and Drug Administration. Public Health Service guideline on infectious disease issues in xenotransplantation (19/01/2001)(Link:http://www.fda.gov/cber/gdlns/xenophs0101.htm).
   Google Scholar
• Michaels MG, Simmons RL. Xenotransplant-associated zoonoses. Strategies for prevention. Transplantation 1994; 57:1–7.
   Google Scholar
• Fishman JA. Xenosis and xenotransplantation: addressing the infectious risk posed by an emerging technology. Kidney Int Suppl 1997;58:S41–5.
   Google Scholar
• Fishman JA. Infection and xenotransplantation. Developing strategies to minimize risk. Ann N Y Acad Sci 1998;862:52–66.
   PubMedGoogle Scholar
• Boneva RS, Folks TM, Chapman LE. Infectious disease issues in xenotransplantation. Clin Microbiol Rev 2001;14:1–14.
   Google Scholar
• Hamilton D. Kidney transplantation: A History. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, London: Grune & Stratton; 1984:1–13.
   Google Scholar
• Starzl TE. Renal heterotransplantation from baboon to man: Experience with 6 cases. Transplantation 1964;2:752–76.
   PubMed Web of Science ®Google Scholar
• Reemstma K. Renal heterotransplantation. Adv Surg 1966;2: 285–93.
   PubMedGoogle Scholar
• Startzl YE, Fung J, Tzakis A, Todo S, Demetris A J, Marino IR, et al. Baboon-to-human liver transplantation. Lancet 1993;341:65–71.
   PubMedGoogle Scholar
• Cooper DK, Keogh AM, Brink J, Corns PA, Klepetko W, Pierson RN, et al. Report of the xenotransplantation advisory committee of the international society for heart and lung transplantation: the present status of xenotrans-plantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transpl 2000; 19:1125–65.
   PubMed Web of Science ®Google Scholar
• Baily LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985;254:3321–9.
   PubMedGoogle Scholar
• Nikonov SD, Tsypin AB, Makarov AA, Denisov AN, Fomin IuR. Initial experience with the use of a xeno-spleen perfusate in the treatment of patients with extensive pyo- destructive diseases of the lungs and pleura. Grud Serdech-nososudistaia Khir 1991;(2):42–5.
   Google Scholar
• Chari RS, Collins BH, Magee JC, DiMaio JM, Kirk AD, Harland RC, et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplan-tation. N Engl J Med 1994;331:234–7.
   PubMedGoogle Scholar
• Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000; 69:272–80.
   PubMedGoogle Scholar
• Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer B, et al. Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999;285:1236–41.
   PubMed Web of Science ®Google Scholar
• Groth CG, Korsgren 0, Wennberg L, Song Z, Wu G, F Reinholt et al . Pig-to-human islet transplantation. Trans-plant Proc 1998;30:3809–10.
   PubMedGoogle Scholar
• Valdes Gonzalez R. Xenotransplantation's benefits outweigh risks. (correspondence) Nature 2002;420:268.
   PubMedGoogle Scholar
• Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, et al. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant 2000;9:273–8.
   Google Scholar
• Bain VG, Montero JL, de La Mata M. Bioartificial liver support. Can J Gastroenterol 2001;15:313–8.
   PubMedGoogle Scholar
• Buscher E, Goddard M, Heyd B, Joseph JM, Favre J, deTribolet N et al. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology 1997;85:1005–12.
   Google Scholar
• Allan JS. The risk of using baboons as transplant donors: Exogenous and endogenous viruses. Ann N Y Acad Sci Xenotransplantation 1998;862:87–99.
   PubMedGoogle Scholar
• Food and Drug Administration. Guidance for industry: Public health issues posed by the use of nonhuman primate xenografts in humans. April 1999; http://www.fda.gov/cber/ gdlns/xenoprim.pdf (Last accesssed December 5,2003).
   Google Scholar
• Smith CEG, Simpson DIH, Bowen ETV/. Fatal human disease from vervet monkeys. Lancet 1967;11:1119–21.
   Google Scholar
• Dalgard DE, Hardy RJ, Pearson SL, Pucak GJ, Quander RV, Zack PM, et al. Combined simian hemorrhagic fever and Ebola virus infection in Cynomolgus Monkeys. Lab Anim Sci 1992;42:152–7.
   PubMedGoogle Scholar
• Huff JL, Barry PA. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg Infect Dis 2003;9:246–50.
   PubMed Web of Science ®Google Scholar
• Weigler BJ. Biology of B virus in macaque and human hosts: a review. Clinical Infect Dis 1992;14:555–67.
   PubMed Web of Science ®Google Scholar
• Khabbaz RF, Heneine W, George JR, Parekh B, Rowe T, Woods T, et al. Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med 1994030: 172–7.
   Google Scholar
• Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, et al. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995;11:161–70.
   PubMed Web of Science ®Google Scholar
• Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D. Simian foamy virus isolated from an accidentally infected human individual. J Virol 1997;71:4821–4.
   Google Scholar
• Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, et al. Identification of a human population infected with simian foamy viruses. Nat Med 1998;4:403–7.
   PubMed Web of Science ®Google Scholar
• Lerche NW, Switzer WM, Yee JL, Shanmugam V, Rosenthal AN, Chapman LE, et al. Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J Virol 2001;75:1783–9.
   PubMed Web of Science ®Google Scholar
• Shah KV, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1–12.
   PubMed Web of Science ®Google Scholar
• Lednicky JA, Butel JS. Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front Biosci 1999;4:d153–64.
   Google Scholar
• Fisher SG, Weber L, Carbone M. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999;19(3B)2173–80.
   Google Scholar
• Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998;279:292–5.
   PubMed Web of Science ®Google Scholar
• Olin P, J, Giescke. . Potential exposure to 5V40 in polio vaccinesused in Sweden during 1957: no impact on cancer incidence rates 1960–1993. Dev Biol Stand 1998;94: 227–33.
   Google Scholar
• Gao F, Bailes E, Robertson DL, Chen Y, Rodenbyrg CM, Michael SF, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436–41.
   PubMed Web of Science ®Google Scholar
• Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000;287:607–14.
   PubMed Web of Science ®Google Scholar
• Bradley R. The research programme on transmissible spongiform encephalopathies in Britain with special refer-ence to bovine spongiform encephalopathy. Dev Biol Stand 1993;80:157–70.
   PubMedGoogle Scholar
• Buhler L, Friedman T, Iacomini J, Cooper DK. Xenotrans-plantation-state of the art-update 1999. Front Biosci 1999;4: D416–32.
   Google Scholar
• Parker W, Saadi S, Lin SS, Holzknecht ZE, Mustos M, Platt JL. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996;17:373–8.
   PubMedGoogle Scholar
• Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995;1:1261–7.
   PubMed Web of Science ®Google Scholar
• Polejaeva IA, Chen SH, Vaught TD, Page RL, Mullins J, Ball S, et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000;407:86–90.
   PubMed Web of Science ®Google Scholar
• Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003;299:411–4.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset FL, et al. Sensitization of cells and retroviruses to human serum by (alpha 1-3)galactosyl-transferase. Nature 1996;379:85–8.
   PubMedGoogle Scholar
• Patience C, Takeuchi Y, Weiss RA. Infection of human cells by endogenous retrovirus of pigs. Nat Med 1997;3:282–6.
   Google Scholar
• McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995;1:423–7.
   PubMed Web of Science ®Google Scholar
• Cozzi E, Bhatti F, Schmoeckel M, Chavez G, Smith KG, Zaidi A, et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xeno-grafts. Transplantation 2000 Jul 15;70(1)15–21.
   Google Scholar
• Adams DH, Kadner A, Chen RH, Farivar RS. Human membrane cofactor protein (MCP, CD46) protects trans-genic pig hearts from hyperacute rejection in primates. Xenotransplantation 2001;8:36–40.
   PubMed Web of Science ®Google Scholar
• Niemann H, Verhoeyen E, Wonigeit K, Lorenz R, Hecker J, Schwinzer R, et al. Cytomegalovirus early promoter induced expression of hCD59 in porcien organs provides protection against hyperacute rejection. Transplantation 2001;72:1898–906.
   PubMed Web of Science ®Google Scholar
• Weiss RA. Transgenic pigs and virus adaptation. Nature 1998;391:327–8.
   PubMed Web of Science ®Google Scholar
• Eastlund T. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 1995;4:455–77.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Hepatitis C virus transmission from an antibody-negative organ and tissue donor-United States, 2000-2002. Morb Mortal Wkly Rep 2003;52:273-4,276.
   PubMedGoogle Scholar
• Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003;348:2196–203.
   PubMed Web of Science ®Google Scholar
• Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997;10:86–124.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chagas disease after organ transplantation-United States, 2001. Morb Mortal Wkly Rep 2002;51:210–2.
   PubMedGoogle Scholar
• Schaffner A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Inf Diseases 2001;33 (Suppl 1)S9–14.
   Google Scholar
• Centers for Disease Control and Prevention. Update: West Nile Virus Screening of Blood Donations and Transfusion-Associated Transmission - United States, 2003. Morbidity and Mortality Weekly Report. 2004);53:281–4.
   PubMedGoogle Scholar
• Hanto DW. Classification of Ebstein-Barr virus associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995;46:381–94.
   PubMedGoogle Scholar
• Food and Drug Administration. Guidance for Industry (Final guidance): Source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans (April 2003) (http://www.fda.gov/cber/gdlns/ clinxeno.htm)Last updated 04/25/2003, accessed December 4, 2003.
   Google Scholar
• Onions D, Cooper DK, Alexander TJ, Brown C, Claassen E, Foweraker JE, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xeno-transplantation 2000;7:143–55.
   PubMed Web of Science ®Google Scholar
• Bone DC, Cramer DV, Phan-Thanh L, Vaillant JC, Bequet JL, Makowka L, et al. Microbiological hazards related to xenotransplantation of porcine organs into man. Infect Control Hosp Epidemiol 1998;19:355–65.
   PubMedGoogle Scholar
• Kumar G, Tuch BE, Deng YM, Rawlinson WD. Limiting potential infectious risks of transplanting insulin-producing pig cells into humans. Pathology 2002;34:178–84.
   PubMed Web of Science ®Google Scholar
• Schumacher JM, Ellias SA, Palmer EP, Kott HS, Dinsmore J, Dempsey PK, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with Parkinson's disease. Neurology 2000;54:1042–50.
   PubMed Web of Science ®Google Scholar
• Shortridge KF, Gao P, Guan Y, Ito T, Kawaoka Y, Markwell D, et al. Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet Microbiol 2000;74:141–7.
   PubMed Web of Science ®Google Scholar
• Chapman LE, Khabbaz RF. Review: Etiology and epidemiol-ogy of the Four Corners hantavirus outbreak. Infect Agents Dis 1994;3: 23/1 '14.
   Google Scholar
• Mackenzie JS, Chua KB, Daniels PW, Eaton BT, Field HE, Hall RA, et al. Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis 2001;7(3 Supp1)497–504.
   Google Scholar
• Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276–8.
   PubMed Web of Science ®Google Scholar
• Boeke JD, Stoye JP. Retrotransposons, endogenous retro-viruses, and the evolution of retroelements. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1997: 343–5.
   Google Scholar
• Patience C, Wilkinson DA, Weiss RA. Our retroviral heritage. Trends Genet 1997;13:116–20.
   PubMed Web of Science ®Google Scholar
• Huang LH, Silberman J, Rothschild H, Cohen JC. Repli-cation of baboon endogenous retrovirus in human cells. Kinetics of DNA synthesis and integration. J. Biol. Chem 1989;264:8811–4.
   Google Scholar
• Armstrong JA, Porterfield JS, De Madrid AT. C-type virus particles in pig kidney cell lines. J Gen Virol 1971;10:195–8.
   Google Scholar
• Lieber MM, Sherr CJ, Benveniste RE, Todaro G J. Biologic and immunologic properties of porcine type C viruses. Virology 1975;66:616–9.
   Google Scholar
• Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Fishman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998;72: 4503–7.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Patience C, Magre S, Weiss RA, Benarjee RA, LeTissier P, et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998;729986–91.
   Google Scholar
• Patience C, Switzer WM, Takeuchi Y, Griffiths DJ, Goward ME, Heneine W, et al. Multiple groups of novel retroviral genomes in pigs and related species. J Virol 2001;75:2771–5.
   PubMedGoogle Scholar
• Bosch S, Arnauld C, Jestin A. Study of full-length porcine endogenous retrovirus genomes with envelope gene poly-morphism in a specific-pathogen-free Large White swine herd. J Virol 2000;74:8575–81.
   Google Scholar
• Martin U, Kiessig V, Blusch JH, Haverich A, von der Helm K, Herden T, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998;352:692–4.
   Google Scholar
• Blusch JH, Patience C, Takeuchi Y, Templin C, Roos C, Von Der Helm K, et al. Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol 2000;74:7687–90.
   Google Scholar
• Ritzhaupt A, Van Der Laan LJ, Salomon DR, Wilson CA. Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines. J Virol 2002;76:11312–20.
   PubMedGoogle Scholar
• Martin U, Winkler ME, Id M, Radecke H, Arseniev L, Groteluschen R, et al. Transmission of pig endogenous retrovirus to primary human cells. Transplant Proc 2000;32: 1157.
   PubMedGoogle Scholar
• Martin U, Winkler ME, Id M, Radeke H, Arseniev L, Takeuchi Y, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000;7:138–42.
   PubMedGoogle Scholar
• Specke V, Rubant S, Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 2001;285:177–80.
   Google Scholar
• Wilson CA, Wong S, Muller J, Davidson CE, Rose TE, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998;72:3082–87.
   PubMed Web of Science ®Google Scholar
• Martin U, Kiessig V, Blusch J, Haverich A, von der Helm K, Herden T, et al. Expression of pig endogenous retrovirus by primary endothelial cells and infection of human cells. Lancet 1998;359:692–94.
   Google Scholar
• Oldmixon BA, Wood JC, Ericsson TA, Wilson CA, White-Scharf ME, Andersson G, et al. Porcine endogenous retro-virus transmission characteristics of an inbred herd of miniature swine. J Virol 2002;76:3045–8.
   Google Scholar
• Ericsson TA, Takeuchi Y, Templin C, Quinn G, Farhadian SF, Wood JC, et al. Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci USA 2003; 100: 6759–64.
   PubMedGoogle Scholar
• Krach U, Fischer N, Czauderna F, Tonjes RR. Comparison of replication-competent molecular clones of porcine en-dogenous retrovirus class A and class B derived from pig and human cells. J Virol 2001;75:5465–72.
   PubMedGoogle Scholar
• Czauderna F, Fischer N, Boller K, Kurth R, Tonjes RR. Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol 2000;74:4028–38.
   Google Scholar
• Tonjes RR, Czauderna F, Fischer N, Krach U, Boller K, Chardon P, et al. Molecularly cloned porcine endogenous retroviruses replicate on human cells. Transplant Proc 2000; 32:1158–61.
   PubMedGoogle Scholar
• Langford GA, Galbraith D, Whittam A J, McEwan P, Fernandez-Suarez XM, Black J, et al. In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation 2001;72:1996–2000.
   Google Scholar
• Specke V, Schuurman HJ, Plesker R, Coulibaly C, Ozel M, Langford G, et al. Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol 2002;9:281–8.
   PubMedGoogle Scholar
• Zhang L, Dailey PJ, He T, Gettie A, Bonhoeffer S, Perelson AS, Ho DD. Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J Virol 1999; 73:855–60.
   Google Scholar
• Igakura T, Stinchcombe JC, Goon PKC, Taylor GP, Weber JN, Griffiths GM, et al. Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cyto-skeleton. Science 2003;299:1713–6.
   PubMed Web of Science ®Google Scholar
• Van der Laan LJ, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000;407:90–4.
   PubMed Web of Science ®Google Scholar
• Deng YM, Tuch BE, Rawlinson WD. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 2000;70:1010–6.
   Google Scholar
• Martin U, Steinhoff G, Kiessig V, Chikobava V, Anssar M, Morschheuser T, et al. Porcine endogenous retrovirus was not transmitted from transplanted endothelial cells to baboons in vivo. Transpl Int 1998;11:247–51.
   PubMedGoogle Scholar
• Switzer WM, Michler RE, Shanmugam V, Matthews A, Hussain Al, Wright A, et al. Lack of cross-species transmis-sion of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation 2001;71:959–65.
   PubMed Web of Science ®Google Scholar
• Martin U, Steinhoff G, Chikobava M, Anssar M, Morsch-heuser T, Lapin B. Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endo-thelial cells to baboons. Transplant Proc 1999;31:913–4.
   Google Scholar
• Cunningham DA, Herring C, Fernandez-Suarez XM, Whit-tam AJ, Paradis K, Langford GA. Analysis of patients treated with living pig tissue for evidence of infection by porcine endogenous retroviruses. Trends Cardiovasc Med 2001; 11: 190–6.
   Google Scholar
• Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME. No evidence of pig DNA or retroviral infection in patients with short-term extracorpor-eal connection to pig kidneys. Lancet 1998;352:699–701.
   Google Scholar
• Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998;352:695–9.
   PubMed Web of Science ®Google Scholar
• Check E. Diabetes trial stirs debate on safety of xenotrans-plants. (Comment) Nature 2002;420:268.
   Google Scholar
• Heneine W, Switzer WM, Soucie JM, Evatt BL, Shanmugam V, Rosales GV, et al. Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of trans-mission to recipients with hemophilia. J Infect Dis 2001;183: 648–52.
   PubMedGoogle Scholar
• Rasheed S. Retroviruses and oncogenes. In: Levy JA, ed. The Retroviridae, Volume 4, Plenum Press New York 1995293–7.
   Google Scholar
• Patience C, Wilkinson D, Weiss RA. Our retroviral heritage. Trends Genet 1997;13:116–120.
   PubMed Web of Science ®Google Scholar
• Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176:1125–35.
   PubMed Web of Science ®Google Scholar
• Purcell DF, Broscius CM, Vanin EF, Buckler CE, Nienhuis AW, Martin MA. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol 1996;70:887–97.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Le Boulch P, et al. LMO-2 associated clonal T cell proliferation in two patients after gene therapy for SCID X-1. Science 2003;302: 415–19.
   Google Scholar
• Ogle BM, Butters KA, Plummer TB, Ring KR, Knudsen BE, Litzow MR, et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo. FASEB J 2004;18:548–50.
   PubMedGoogle Scholar
• Mathews A, Brown J, Switzer W, Folks TM, Heneine W, Sandstrom P. Development and validation of a western immunoblot assay for detection of antibodies to porcine endogenous retrovirus. Transplantation 1999;67:939–43.
   PubMedGoogle Scholar
• Tacke SJ, Specke V, Stephan 0, Seibold E, Bodusch K, Denner J. Porcine endogenous retroviruses: diagnostic assays and evidence for immunosuppressive properties. Transplant Proc 2000;32: 1166.
   Google Scholar
• Tacke SJ, Bodusch K, Berg A, Denner J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xeno-transplantation. Xenotransplantation 2001;8:125–35.
   PubMedGoogle Scholar
• Galbraith DN, Kelly HT, Dyke A, Reid G, Haworth C, Beekman J, Shepherd A, Smith KT. Design and validation of immunological tests for the detection of porcine endogenous retrovirus in biological materials. J Virol Methods 2000;90: 115–24.
   PubMedGoogle Scholar
• Stephan 0, Schwendemann J, Specke V, Tacke SJ, Boller K, Denner J. Porcine endogenous retroviruses (PERVs): genera-tion of specific antibodies, development of an immuno-peroxidase assay (IPA) and inhibition by AZT. Xenotransplantation 2001;8: 310–6.
   Google Scholar
• Switzer WM, Shanmugan V, Chapman L, Heneine W. Polymerase chain reaction for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. Transplantation 1999;68:183–8.
   PubMedGoogle Scholar
• Argaw T, Ritzhaupt A, Wilson CA. Development of a real time quantitative PCR assay for detection of porcine endogenous retrovirus. J Virol Methods 2002;106:97–106.
   Google Scholar
• Herring C, Cunningham DA, Whittam AJ, Fernandez-Saurez XM, Langford GA. Monitoring xenotransplant recipients for infection by PERV. Clin Biochem 2001;34:23–7.
   Google Scholar
• Shih A, Misra R, Rush MG. Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses. J Virol 1989;63:64–75.
   Google Scholar
• Heneine W, Yamamoto S, Switzer WM, Spira TJ, Folks TM. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. J Infect Dis 1995;171: 1210–6.
   Google Scholar
• Woese C. The universal ancestor. Proc Natl Acad Sci USA 1998;95:6854–9.
   PubMed Web of Science ®Google Scholar
• Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946–51.
   Google Scholar
• Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowless DM, Moore PS. Identification of herpes-like DNA sequences in AIDS- associated Kaposi's sarcoma. Science 1994;226:359–62.
   Google Scholar
• Relman DA. Detection and identification of previously unrecognized microbial pathogens. Emerg Infect Dis 1998; 4:382–9.
   PubMedGoogle Scholar
• Mueller NJ, Barth RN, Yamamoto S, Kitamura H, Patience C, Yamada K, et al. Activation of cytomegalovirus in pig-to- primate organ xenotransplantation. J Virol 2002;76:473110.
   Google Scholar
• Switzer WM, Bhullar V, Shanmugan V, Cong M, Parekh B, Lerche N, et al. Frequent simian retrovirus infection in persons occupationally exposed to nonhuman primates. J Virol 2004:In press.
   Google Scholar
• Boneva RS, Grindon AJ, Orton SL, Switzer WM, Shanmu-gam V, Hussain Al, et al. Simian foamy virus infection in a blood donor. Transfusion 2002;42:886–91.
   Google Scholar
• Stoye J. No clear answers on safety of pigs as tissue donor source. Lancet 1998;352:666–7.
   PubMed Web of Science ®Google Scholar
• Drosten C, Gunther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, et al. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. N Engl J Med 2003;348:1967–76.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N Engl J Med 2003;348:1953–66.
   PubMed Web of Science ®Google Scholar
• Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong. N Engl J Med 2003;348:1986–94.
   PubMed Web of Science ®Google Scholar
• Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968;219:972–3.
   PubMedGoogle Scholar
• Kaiser J. Gene therapy. RAC hears a plea for resuming trials, despite cancer risk. Science 2003;299:991.
   Google Scholar
• FDA. Guidance for Industry Precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts. http://www.fda.gov/cber/ gdlns/zooxeno.htm#iii(Last updated May 15, 2001; last accessed December 9, 2003).
   Google Scholar